EC
EcoR1 Capital Portfolio holdings
AUM
$1.69B
This Quarter Return
+36.32%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$924M
AUM Growth
+$924M
(+6.3%)
Cap. Flow
-$175M
Cap. Flow
% of AUM
-18.9%
Top 10 Holdings %
Top 10 Hldgs %
69.3%
Holding
56
New
7
Increased
7
Reduced
13
Closed
17
Top Buys
| 1 |
CRISPR Therapeutics
CRSP
|
$59.6M |
| 2 |
Ultragenyx Pharmaceutical
RARE
|
$34.5M |
| 3 |
Xencor
XNCR
|
$33.2M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$25.9M |
| 5 |
Gossamer Bio
GOSS
|
$16.7M |
Top Sells
| 1 |
FibroGen
FGEN
|
$73.7M |
| 2 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$69.2M |
| 3 |
Ionis Pharmaceuticals
IONS
|
$39.2M |
| 4 |
Ascendis Pharma
ASND
|
$37.5M |
| 5 |
Assembly Biosciences
ASMB
|
$24.6M |
Sector Composition
| 1 | Healthcare | 88.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
argenx
ARGX
$43.6B
| $103M | 9.5% | 825,087 | – | – |
|
2
Kura Oncology
KURA
$686M
| $87.5M | 8.07% | 5,276,753 | – | – |
|
|
MRTX
3
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $73.3M | 6.76% | 1,000,000 +352,831 | +55% | +$25.9M |
|
|
4
CRISPR Therapeutics
CRSP
$4.71B
| $67.1M | 6.18% | 1,878,277 +1,669,427 | +799% | +$59.6M |
|
|
5
Xencor
XNCR
$580M
| $64M | 5.9% | 2,059,429 +1,070,411 | +108% | +$33.2M |
|
|
ONCE
6
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $60.2M | 5.55% | 529,000 -607,851 | -53% | -$69.2M |
|
7
Ironwood Pharmaceuticals
IRWD
$214M
| $59.5M | 5.48% | 4,397,168 -984,114 | -18% | -$13.3M |
|
|
DRNA
8
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $48.6M | 4.48% | 3,316,407 | – | – |
|
|
9
Ascendis Pharma
ASND
$11.8B
| $42.5M | 3.91% | 360,819 -318,927 | -47% | -$37.5M |
|
|
10
Ultragenyx Pharmaceutical
RARE
$2.89B
| $34.5M | 3.18% | +497,899 | New | +$34.5M |
|
|
MYOK
11
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $24.9M | 2.29% | 478,574 +244,193 | +104% | +$12.7M |
|
|
12
Assembly Biosciences
ASMB
$190M
| $22.7M | 2.09% | 1,153,599 -1,251,254 | -52% | -$24.6M |
|
|
EIGR
13
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $22.3M | 2.06% | 1,595,643 | – | – |
|
14
Dianthus Therapeutics
DNTH
$759M
| $21M | 1.94% | 1,277,787 -101,700 | -7% | -$1.67M |
|
|
15
Gossamer Bio
GOSS
$562M
| $16.7M | 1.54% | +772,096 | New | +$16.7M |
|
|
CHMA
16
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $15.8M | 1.46% | 3,043,827 +2,664,074 | +702% | +$13.9M |
|
17
Kezar Life Sciences
KZR
$28.9M
| $15.2M | 1.4% | 856,471 -203,547 | -19% | -$3.61M |
|
|
HARP
18
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $12.7M | 1.17% | +1,336,423 | New | +$12.7M |
|
19
Arcus Biosciences
RCUS
$1.13B
| $12.4M | 1.14% | 990,146 -233,349 | -19% | -$2.91M |
|
20
Mersana Therapeutics
MRSN
$36.5M
| $12.1M | 1.12% | +2,300,000 | New | +$12.1M |
|
|
RUBY
21
DELISTED
Rubius Therapeutics, Inc
RUBY
| $11.7M | 1.08% | 646,228 +54,100 | +9% | +$979K |
|
22
Rhythm Pharmaceuticals
RYTM
$6.85B
| $11M | 1.01% | 400,838 | – | – |
|
|
SURF
23
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $10.8M | 1% | 2,263,488 +2,160 | +0.1% | +$10.3K |
|
|
24
FibroGen
FGEN
$47.8M
| $9.15M | 0.84% | 168,382 -1,356,175 | -89% | -$73.7M |
|
25
Prothena Corp
PRTA
$441M
| $8.81M | 0.81% | 726,519 -111,700 | -13% | -$1.35M |
|